1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Craniofacial Pain

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Craniofacial Pain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Farooqui, AA; Ong, WY; Vahidy, WH; Yeo, JF	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Craniofacial Pain

Article	Year
Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain. Experimental brain research, 2006, Volume: 174, Issue:4 Topics: Animals; Carrageenan; Disease Models, Animal; Drug Therapy, Combination; Facial Pain; Fatty Acids, Nonesterified; Injections, Intraventricular; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Pain Measurement; Platelet Activating Factor; Time Factors	2006

Article

Year

Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain.

Experimental brain research, 2006, Volume: 174, Issue:4

Topics: Animals; Carrageenan; Disease Models, Animal; Drug Therapy, Combination; Facial Pain; Fatty Acids, Nonesterified; Injections, Intraventricular; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Pain Measurement; Platelet Activating Factor; Time Factors

2006